The phrase "approved for clinical application" is correct and usable in written English.
It can be used in contexts related to medical research, pharmaceuticals, or healthcare to indicate that a treatment or procedure has received official authorization for use in clinical settings.
Example: "The new drug has been approved for clinical application after extensive trials demonstrated its efficacy and safety."
Alternatives: "authorized for clinical use" or "validated for clinical practice".
However, none of the tested agents were approved for clinical application [24].
Vorinostat (SAHA) is structurally similar to TSA and the first HDACi to be approved for clinical application [86], [87].
CGMS [ 11] was designed and developed by Medtronic (Medtronic MiniMed) and has been approved for clinical application in the USA.
Consequently, there are a number of anti-VEGF drugs approved for clinical application [ 4, 5] or in clinical testing [ 6, 7].
However, this contrast-agent has not been approved for clinical application yet, and identification of metastatic lymph nodes, based solely on morphological criteria, remains challenging [ 10– 10].
None of these tissue-engineered bone substitutes has been registered in Russia as a medical product approved for clinical application, although successful results in the area have been obtained since the 1980s [ 125, 126].
Some of the developed products have been approved for clinical applications.
Y-TZP is a biocompatible material already approved for clinical applications, and herein, Y-TZP specimens were set up as the control group.
Ever since proteasome inhibitors have come to prominence as potent inducers of apoptosis in cancer cells and have been approved for clinical applications, it has been speculated that proteasome inhibitors kill by a mechanism unrelated to the mode of action of other more conventional chemotherapeutic drugs.
Only approximately 5% of anticancer agents evaluated in human studies between 1991 and 2000 were successfully approved for clinical applications [ 152, 154].
The first technological trend includes the majority of bone grafts approved for clinical applications that do not contain biologically active components standardized by qualitative and quantitative parameters.
